• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

real-world data (RWD)

Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD

by Jasmine Pennic 10/29/2020 Leave a Comment

Medidata, TriNetX, Datavant Partner to Accelerate Use of RWD

What You Should Know: - Today, Medidata, TriNetX, and Datavant announced a partnership to accelerate the use of real-world data (RWD) to power clinical research. - Linking RWD, which is data not collected during the specific context of a clinical trial, can help improve understanding of the long-term safety and efficacy of new therapies.  Medidata, a Dassault Systèmes company, TriNetX, and Datavant announced a partnership that will accelerate the use of real-world data (RWD) to
Read More

TriNetX Acquires European Clinical Data Network InSite

by Jasmine Pennic 04/02/2019 Leave a Comment

TriNetX Acquires European Clinical Data Network InSite

TriNetX, a global health research network that revolutionizes clinical research and enables discoveries through the generation of real-world evidence (RWE) has acquired Belgium-based Custodix NV and its InSite network. InSite network is a European-based provider of services for clinical trial design, patient feasibility, and enabling workflow for patient recruitment. Financial details of the acquisition were not disclosed. InSite Clinical Data Network Background The InSite platform is an
Read More

TriNetX Lands $40M to Expand Global Health Research Network

by Jasmine Pennic 03/15/2019 Leave a Comment

TriNetX Lands $40M to Expand Global Health Research Network

TriNetX, a Cambridge, MA-based global health research network that optimizes clinical research and enables discoveries through the creation of real-world evidence (RWE) has raised $40 million in Series D funding. The Series D funding round was led by Merck Global Health Innovation Fund (Merck GHIF) along with new investors Mitsui & Co., Ltd., ITOCHU Technology Ventures, ITOCHU Corporation, and existing investors MPM Capital, F2 Ventures, and Deerfield Management. To date, TriNetX has raised
Read More

Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities

by Jasmine Pennic 07/25/2018 Leave a Comment

Carilion Clinic Joins TriNetX Network to Expand Clinical Research and Collaboration Opportunities

TriNetX, the global health research network, will announce the latest addition to its research network: Carilion Clinic, a not-for-profit healthcare organization based in Roanoke, Virginia. By joining the network, Carilion will enhance its researchers’ ability to quickly execute clinical trials and collaborate with other industry TriNetX network members. Carilion, serves nearly one million residents and owns and operates seven hospitals, more than 225 outpatient practices, and Jefferson College
Read More

Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data Via TriNetX

by Jasmine Pennic 06/12/2018 Leave a Comment

Cardiovascular Research Consortium to Provide Access to Real-World Heart Care Data

Today TriNetX, the global health research network, announced that the Cardiovascular Research Consortium (CRC) has selected TriNetX’s real-world evidence platform to provide the biopharma industry with the first-of-its-kind access to extensive cardiology-specific clinical data. The CRC is a nationwide network of community-based cardiology practices and is one of the largest searchable cardiology patient bases in the U.S, treating an upwards of 3 million patients across 30+ states. Heart disease
Read More

Can NLP Text-Mining Transform Drug Discovery & Development for Biopharma?

by Jane Reed, Head of Life Science Strategy at Linguamatics 01/31/2018 Leave a Comment

Can NLP Text-Mining Transform Drug Discovery & Development for Biopharma?

Healthcare is in the midst of a data explosion, thanks to the widespread adoption of electronic health records (EHRs), the increased sophistication of insurance claims databases, and the growth of social media. These real-world data provide critical insights into the health of patients and can be leveraged to advance pharma and biotech initiatives that improve the delivery of care.This wealth of clinical data is particularly valuable for organizations seeking to understand the real-world impact
Read More

  • Previous Page
  • Go to page 1
  • Go to page 2
  • Go to page 3
  • Go to page 4

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

2019 MedTech Breakthrough Award Category Winners Announced

MedTech Breakthrough Announces 2025 MedTech Breakthrough Award Winners

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |